Editas Medicine Inc.

NASDAQ: EDIT · Real-Time Price · USD
3.04
0.08 (2.70%)
At close: Aug 15, 2025, 3:59 PM
2.97
-2.30%
After-hours: Aug 15, 2025, 05:09 PM EDT

Editas Medicine Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-53.23M -76.09M -45.4M -62.14M -67.61M -61.95M -18.87M -45.02M -40.29M -49.04M -60.74M -55.73M -53.45M -50.52M -41.44M -39.08M -55.26M -56.73M
Depreciation & Amortization
1.58M 1.92M 1.38M -3.32M 1.42M 1.41M 1.47M 1.51M 1.54M 1.54M 1.58M 1.6M 1.6M 1.56M 1.51M 1.19M 1.19M 1.16M
Stock-Based Compensation
2.66M 2.98M 4.02M 4.8M 5.01M 7.58M 5.34M 4.73M 5.21M 4.51M 5.36M 5.88M 6.62M 11.43M 7.66M 10.01M 13.53M 12.2M
Other Working Capital
n/a 1.89M 11.04M 5.47M -1.01M -3.69M 2.27M 2.34M -1.65M 1.98M 14.35M -495K 5.43M -10.6M -11.33M -5.67M -151K -5.55M
Other Non-Cash Items
-1.22M 5.78M 1.33M 3.73M -2.29M -1.72M 16.55M -3.04M -780K 890K -498K -283K -177K 234K 325K 422K 509K 401K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -18.64M 1.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a 17.61M -12.1M 4.34M 6.41M 4.8M -8.09M 4.56M -4.4M 6.33M 12.02M 520K 7.57M -11.94M -2.64M -13.33M 1.07M -6.52M
Operating Cash Flow
-50.21M -47.8M -50.76M -52.59M -57.06M -49.87M -22.24M -35.46M -38.71M -35.77M -42.27M -48M -37.84M -49.23M -34.58M -40.78M -38.96M -49.48M
Capital Expenditures
n/a -114K -540K -2.92M -3.49M -1.87M -1.31M -239K -1.33M -1.84M -624K -614K -632K -2.25M -2.85M -2.34M -2.7M -84K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -64.15M 102.58M -14.31M -25.11M -118.17M -89.84M 18K n/a 46.49M n/a n/a n/a
Purchase of Investments
n/a n/a 4K n/a 3K -86.22M -38.75M -151.58M -27.39M -40.8M -105.4M -26.26M -123.14M -60.38M -104.32M -110.44M -66.7M -127.42M
Sales Maturities Of Investments
42.5M 56.5M 31.49M 86.9M 55.45M 83.35M 102.9M 49M 41.7M 65.91M 78.5M 116.1M 119.75M 119M 84.33M 73.13M 74.2M 130.75M
Other Investing Acitivies
151K n/a n/a n/a n/a n/a 64.15M -102.58M 14.31M 25.11M 118.17M 89.84M -3.37M 58.62M -46.49M -37.32M 7.5M 3.33M
Investing Cash Flow
42.65M 56.39M 30.96M 83.98M 51.95M -4.75M 62.84M -102.82M 12.98M 23.27M -27.53M 89.23M -4M 56.37M -22.84M -39.66M 4.79M 3.24M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
228K n/a n/a 322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
7.41M -2.87M n/a n/a n/a n/a n/a n/a 117.53M n/a 619K 80K 367K 218K 1.06M 2.5M 17.08M 12M
Financial Cash Flow
7.41M -1.44M 55.51M n/a 322K 192K 514K n/a 117.53M n/a 619K 80K 367K 218K 1.06M 2.5M 17.08M 261.47M
Net Cash Flow
-150K 7.15M 35.71M 31.39M -4.79M -54.42M 41.12M -138.28M 91.8M -12.5M -69.18M 41.3M -41.48M 7.36M -56.37M -77.95M -17.08M 215.24M
Free Cash Flow
-50.21M -47.91M -51.3M -55.51M -60.56M -51.74M -23.55M -35.7M -40.04M -37.61M -42.9M -48.62M -38.48M -51.48M -37.43M -43.13M -41.66M -49.56M